Liu Wuqianhui, Zhang Haitao, He Yuan
The First School of Clinical Medicine, Nanjing Medical University, Nanjing 211166, China.
The Research Center for Medical Security, China Pharmaceutic University, Nanjing 211166, China.
Int J Environ Res Public Health. 2021 Jul 12;18(14):7420. doi: 10.3390/ijerph18147420.
The Coronavirus Disease 2019 (COVID-19) exerts variable impact on patients with obsessive compulsive disorders (OCD). There remains a challenge to determine the extent to which OCD is exacerbated due to the pandemic. Therefore, our aim is to explicate the latest researching progress of OCD under COVID-19 based on a review of 15 existing articles. Our review confirms the prevalence of OCD exacerbation in different age groups and particular symptoms. However, it also reveals nonconformity among research, lack of investigation in OCD treatment, and imbalance in OCD symptoms research. Further, we discuss the probable reasons of the exacerbation and current situation of OCD treatments. Finally, based on our discussion, we offer suggestions on how to manage OCD under the new circumstance, including the introduction of new policies, the use of communications technology, the improvement of researching methods, and possible angles for further research.
2019年冠状病毒病（COVID-19）对强迫症（OCD）患者产生了不同程度的影响。确定强迫症在多大程度上因疫情而加剧仍然是一个挑战。因此，我们的目的是通过对15篇现有文章的综述来阐述COVID-19背景下强迫症的最新研究进展。我们的综述证实了强迫症在不同年龄组和特定症状中的加重情况。然而，它也揭示了研究之间的不一致、对强迫症治疗缺乏调查以及强迫症症状研究的不平衡。此外，我们讨论了强迫症加重的可能原因和治疗现状。最后，基于我们的讨论，我们就如何在新情况下管理强迫症提出了建议，包括出台新政策、使用通信技术、改进研究方法以及进一步研究的可能角度。
